DKK185.50
0.91% yesterday
Copenhagen, Jun 13, 05:00 pm CET
ISIN
DK0060027142
Symbol
ALK B
Sector
Industry

Alkello A S Stock price

DKK185.50
+19.40 11.68% 1M
+32.40 21.16% 6M
+26.40 16.59% YTD
+40.20 27.67% 1Y
+94.25 103.29% 5Y
+144.65 354.10% 10Y
-706.50 79.20% 20Y
Copenhagen, Closing price Fri, Jun 13 2025
-1.70 0.91%
ISIN
DK0060027142
Symbol
ALK B
Sector
Industry

Key metrics

Market capitalization DKK41.74b
Enterprise Value DKK42.02b
P/E (TTM) P/E ratio 44.26
EV/FCF (TTM) EV/FCF 2,334.59
EV/Sales (TTM) EV/Sales 7.36
P/S ratio (TTM) P/S ratio 7.31
P/B ratio (TTM) P/B ratio 7.31
Revenue growth (TTM) Revenue growth 15.52%
Revenue (TTM) Revenue DKK5.71b
EBIT (operating result TTM) EBIT DKK1.24b
Free Cash Flow (TTM) Free Cash Flow DKK18.00m
Cash position DKK517.00m
EPS (TTM) EPS DKK4.23
P/E forward 34.96
P/S forward 6.74
EV/Sales forward 6.79
Show more

Is Alkello A S a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Alkello A S Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Alkello A S forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Alkello A S forecast:

Buy
83%
Hold
17%

Financial data from Alkello A S

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5,708 5,708
16% 16%
100%
- Direct Costs 2,029 2,029
12% 12%
36%
3,679 3,679
18% 18%
64%
- Selling and Administrative Expenses 1,907 1,907
7% 7%
33%
- Research and Development Expense 530 530
10% 10%
9%
1,521 1,521
51% 51%
27%
- Depreciation and Amortization 277 277
10% 10%
5%
EBIT (Operating Income) EBIT 1,244 1,244
65% 65%
22%
Net Profit 937 937
69% 69%
16%

In millions DKK.

Don't miss a Thing! We will send you all news about Alkello A S directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.

Head office Denmark
CEO Peter Halling
Employees 2,753
Founded 1923
Website www.alk.net

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today